ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New

Frontiers A Systematic Review of Opioid Use Disorder and Related Biomarkers

ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD)

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions

TESCREAL hallucinations: Psychedelic and AI hype as inequality engines in: Journal of Psychedelic StudiesOnline First

ANANDA Scientific

Nantheia ATL5: A New Hope for Beating Opioid Addiction - Treatment Magazine

The Opioid Crisis and Recent Federal Policy Responses

2024 Pipeline Report: First-World Focus

Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria

Neurological Archives - Page 2 of 21 - Drug Delivery Business

ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)